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Abstract 
 
Introduction: Cardiac surgery with cardiopulmonary bypass (CPB) induces postoperative 
immunosuppression and impaired pulmonary function. Maintaining mechanical ventilation 
(MV) during CPB improves pulmonary function and diminishes postoperative systemic 
inflammation. However, there is no data about the influence of maintaining MV during CPB 
on postoperative immune dysfunction. 
Material and methods: 50 patients were prospectively divided into two groups: without MV 
during bypass (n=25) and dead space MV with PEEP (n = 25). PaO2/FiO2 ratio, CXCL10, 
CCL2, TNF-α, IL-10, HLA-DR, monocytic myeloid-derived suppressor cells (Mo-MDSC, 
CD14+HLA-DRlo/- monocytes) and blood cell count were collected before and after surgery.  
Results: CPB induced a marked immunosuppression with a significant increase of plasmatic 
levels of TNF-α and IL-10, and a significant decrease in HLA-DR monocytic expression. The 
postoperative proportion of Mo-MDSC was subsequently significantly increased. Maintaining 
MV during CPB significantly improved PaO2/FiO2 ratio and decreased postoperative 
plasmatic levels of TNF-α and IL-10 compared to patients without MV during CPB. 
Furthermore, non-ventilated patients had a lower lymphocyte count after surgery compared 
to patients with MV during CPB.  
Conclusion: Our study suggests that maintaining MV during CPB for cardiac surgery 
decreases postoperative immune dysfunction and could be an interesting strategy to 
diminish the occurrence of postoperative nosocomial infection without hampering the surgical 
procedure. However, these findings have to be confirmed in a clinical trial using the 
incidence of nosocomial infection as an endpoint. 
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Introduction 
 
Cardiopulmonary bypass (CBP) during cardiac surgery induces a systemic inflammatory 
response associated with an immune dysregulation and a significant pulmonary dysfunction 
[1-5]. These two phenomena have been well characterized. Firstly, the inflammatory 
response, usually attributed to surgical trauma, contact of blood with artificial surfaces and 
ischemia-reperfusion injury, is responsible for a postoperative immunodepression. Mekontso 
et al. have shown that bactericidal activity of polymorphonuclear neutrophils against 
Staphylococcus aureus was decreased after cardiac surgery [3]. In a prospective study, 
Chalk et al. have also reported a dysfunction of pulmonary macrophages after CPB. In 
particular, they have described an early impairment of lung cellular immune response, which 
could promote the development of postoperative pneumonia [6]. Along these lines, a down-
regulation of human leucocyte antigen-DR antigen (HLA-DR) expression on monocytes and 
an increase of plasma interleukine (IL)-10 associated with the occurrence of nosocomial 
infections have been reported [4,6,7]. Secondly, CPB induces a pulmonary dysfunction which 
ranges from a temporary and clinically insignificant reduction in arterial oxygenation to a life-
threatening injury manifested as acute respiratory distress syndrome. This phenomenon is of 
multifactorial sources but one of the main mechanisms is the occurrence of atelectasis during 
surgery [8-15]. Atelectasis have been associated with lung injury and release of cytokines 
(TNF-α) by shear forces on alveoli and small airways [12-15]. However, it is not clear 
whether this injury is due to a recruitment/de-recruitment phenomenon (ie atelectrauma) or 
whether it might by itself lead to the release of cytokines [15-17]. Nevertheless, addition of a 
positive end-expiratory pressure (PEEP) during CPB for cardiac surgery diminished the 
occurrence of atelectasis and the postoperative inflammatory response without hampering 
the surgical progress [10-12].  
Since maintaining mechanical ventilation (MV) with PEEP during CPB diminishes 
postoperative inflammation, a relationship between pulmonary dysfunction and postoperative 
immunosuppression should be investigated. We thus conducted a prospective study to 
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investigate the effects of maintaining lung ventilation during CPB in patients undergoing 
cardiac surgery on postoperative immune dysfunction using IL-10 and HLA-DR as major 
endpoints. We also investigated the CD14+HLA-DRlo/- monocytes, which have been 
described as immunosuppressive monocytic myeloid derived suppressor cells (Mo-MDSC) in 
humans [18-20], before and after CPB. 
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Materials and methods 
 
Patient population 
All patients were > 18 years old and were scheduled for cardiac surgery using cardio-
pulmonary bypass (valve replacement and/or coronary artery bypass grafting). 
Exclusion criteria were as follows: systemic steroid therapy, chronic lung diseases (including 
chronic obstructive or restrictive pulmonary diseases), left ventricular dysfunction (left 
ventricular ejection fraction <50%) and the need for vasopressor or inotropic agents before 
surgery. 
 
Anaesthesia, CPB, and surgical procedure 
General anaesthesia was induced with propofol, sufentanil 0.3μg/kg and was followed by 
cisatracurium 0.15 mg/kg for muscular relaxation. Anaesthesia, muscle relaxation and 
analgesia were respectively maintained with inhalated sevoflurane during off-pump surgery 
or propofol infusion during CPB, boluses of atracurium and sufentanil. Baseline ventilation: 
the patients received volume-controlled ventilation with a tidal volume of 8 mL/kg of predicted 
body weight (PBW) and a ventilatory frequency of 10–15 b.p.m. (PETCO2 between 34 and 
38 mmHg). Inspired oxygen fraction (FiO2) was 0.50, inhalation: exhalation ratio was 1:2, and 
the level of positive end-expiratory pressure (PEEP) was 5 cmH2O.  
During CPB, two settings were used depending on the surgeon in charge: (1) absence of 
mechanical ventilation (and no positive end-expiratory pressure) by disconnecting the 
tracheal tube from the ventilator (MV- group), (2) dead space ventilation using tidal volume of 
2.5 mL/kg (predicted body weight, PBW) with 5cmH2O PEEP (MV+ group). After CPB, 
ventilatory parameters were turned back to to baseline settings and no recruitment 
manoeuvres were performed before oxygenation determination.  PaO2 /FiO2 was obtained 
before surgery (after induction of anaesthesia) and 3 h after the end of CPB in the surgical 
intensive care unit (under baseline mechanical ventilation settings). We took advantage of 
the different ventilatory settings that are commonly used by the surgeon and the anaesthetist 
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in charge: consequently, the patients were not randomised in the different ventilatory settings 
for the purpose of this study. The study was approved by our Local Ethics Committee. 
Patients were informed of the observational nature of the study and gave their consent. The 
design of the study is summarized in Figure 1A. 
 
 
 
Study procedures. 
Blood samples treated with heparin were collected for all patients immediately after induction 
of anesthesia (T1) and within an hour following the end of intervention (T2). The delay 
between blood sampling and the beginning of laboratory procedures was <1h. Plasma 
samples were stored at -80°C until use.  
 
Flow cytometry. The level of HLA-DR expression on monocytes was measured on whole 
blood using fluorescein isothiocyanate-conjugated anti-human leukocyte antigen DR (HLA-
DR-FITC, Beckman Coulter) with isotype- and fluorophore-matched control to confirm 
binding specificity, and phyco-erythrin-cyanin-7 anti-CD14 antibody (CD14-PC7; Beckman 
Coulter). Samples were run on a flow cytometer (Navios, Beckman Coulter) and data were 
analysed using Kaluza software (Beckman Coulter). Monocytes were characterized on the 
basis of their CD14 expression (See Figure 1B for gating strategy). 
 
ELISA 
TNF-α, IL-10, C-X-C motif chemokine 10 (CXCL10) and chemokine ligand 2 (CCL2) were 
quantified by DuoSet ELISA (R&D Systems, Abingdon, UK) in peripheral blood plasma 
according to the manufacturer instructions. 
 
 
Data collection 
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The following data were collected: Age, Body Mass Index (BMI), central venous pressure 
(CVP) and mean pulmonary arterial pressure (mPAP) before and after CPB, PaO2 /FiO2 ratio 
before and after CPB, type of heart surgery (valvular replacement, coronary artery bypass 
grafting (CABG) or mixed), surgery duration, ICU and hospital length of stay. The occurrence 
of postoperative infections (nosocomial infections) within 14 days was also recorded and 
defined as previously described [21]. Lastly, blood cell count with differential (including 
lymphocyte, neutrophil (PMN), and monocyte counts) was collected before and after surgery.  
 
Statistical analysis 
Quantitative variables were expressed as median and interquartile range (IQR). Differences 
observed between groups were analyzed using the nonparametric Mann-Whitney U test. In 
each group, differences between pre- (T1) and post-CBP times (T2) were analyzed using the 
Wilcoxon matched-pairs signed rank test. Correlations between two continuous variables 
were investigated using the nonparametric Spearman rank correlation test. All statistical 
analyses were performed using GraphPad Prism Version 5 (GraphPad Prism Software Inc) 
at a significance level of p < 0.05.  
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Results 
 
Patients characteristics 
50 patients completed the study. The baseline characteristics are given in Table 1. No 
difference was found between the two groups except for body mass index (BMI).  
 
Effects of maintaining MV during CPB on pulmonary function 
The effects of mechanical ventilation on outcome as well as clinical parameters are 
summarized in Table 2. Of note, maintaining MV during CPB did not influence procedure 
duration.  
Maintaining MV during CPB significantly improved postoperative PaO2 /FiO2 ratio (+6% in 
ventilated patients vs. -15% in non-ventilated patients, p= 0.005, Figure 2A). No difference 
was found between the two groups regarding hemodynamic parameters (CVP and mPAP) 
before and after CPB (Table 1). Lastly, MV duration, length of stay in ICU and hospital stay 
were not different between the two groups.  
Plasmatic levels of CXCL10 and CCL2 were significantly increased after cardiac surgery 
(Figure 2B). No difference was found between patients with and without MV during CPB 
(Figure 2C).  
 
CPB during cardiac surgery decreased HLA-DR expression, increased CD14+HLA-DRlow/neg 
monocytes count and induced IL-10 and TNF-α production.  
A significant decrease in HLA-DR expression occurred after CPB (MFI 7.3 [IQR, 5.4 – 9.3] 
before vs 2.8 [2.3 – 3.4] after; p<0.001, Figure 3A). CPB was subsequently associated with a 
significant increase in CD14+HLA-DRlow/neg monocytes (10.3% of CD14+ monocytes [IQR, 3.9 
– 17.4] before vs. 29.5% [IQR, 20.9 – 40.9] after; p<0.0001). TNF-α and IL-10 levels were 
higher after surgery (respectively, 45.24 pg/mL [IQR, 43.14 – 48.47] before vs. 48.47 pg/mL 
[43.14 – 56.14] after; p=0.0183, and 66.77 pg/mL [IQR, 62.78 – 72.95] before vs. 114.7 
pg/mL [IQR, 86.55 – 153.9] after; p<0.0001, Figure 3B).  White blood cell counts were also 
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modified after surgery, compared to WBC before CPB: we found a significant increase in 
PMN count (4.42 /mm3 [IQR, 3.31 – 5.22] before vs. 8.58 /mm3 (IQR, 6.47 – 12.69] after; 
p<0.0001) and a significant decrease in lymphocyte count (1.69 /mm3 [1.34 – 2.205] before 
vs. 1.3 /mm3 [IQR, 0.9 – 1.625] after; p<0.0001), while monocyte count remained unchanged 
(0.63 /mm3 (IQR, 0.53 – 0.795) before vs. 0.63 /mm3 IQR, 0.39 – 0.9] after; ns, Figure 3C). 
Lastly, there was a significant inverse correlation between postoperative levels of IL-10 and 
lymphocytes count (Figure 3D). 
 
 
Effects of maintaining MV during CPB on immune parameters 
Patients ventilated during CPB showed lower levels of TNF-α and IL-10 compared to non-
ventilated patients (44.2 pg/mL [IQR, 42.1 – 48.5] and 98.7 pg/mL [IQR, 86.5 – 129.0] vs. 
53.5 pg/mL [IQR, 48.4 – 64.4] and 129.1 pg/mL [IQR, 89.0 – 198.7], p<0.05 and p<0.05 
respectively, Figure 4A). Furthermore, non-ventilated patients had a lower lymphocyte count 
after surgery compared to patients ventilated during CPB (1.05 /mm3 [IQR, 0.88 – 1.465] vs. 
1.48 /mm3 [IQR, 1.128 – 1.74] respectively, p=0.04, Figure 4B). Lymphocyte count remained 
significantly lower 48 hours after surgery (0.73 /mm3 [IQR, 0.59 – 1.05] vs. 1.36 /mm3 [IQR, 
0.96 – 1.47], p<0.05, Figure 4C).  
No significant difference was found in HLA-DR down-regulation between the two groups (MFI 
(T2-T1) -4.3 [IQR, -6.7 - -2.4] in non-ventilated patients vs. -3.8 [IQR, -5.0 - -2.8] in ventilated 
patients; ns, Figure 4D). Consequently, CD14+HLA-DRlow/neg monocytes count was not 
different between the two groups (32.23% of CD14+ monocytes [IQR, 24.23 – 40.40] in non-
ventilated patients vs. 24.87% [IQR, 15.81 – 41.73] in ventilated patients; p=0.2, Figure 4E).  
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Discussion 
 
Our results suggested that maintaining MV during cardiac surgery with CPB could be of 
interest to decrease postoperative immunosuppression. We found that patients ventilated 
during CPB had lower postoperative levels of immunosuppressive IL-10 and proinflammatory 
TNF-α, and a higher postoperative lymphocytes count. However, the proportion of 
CD14+HLA-DRlo/- monocytes was not statistically different between both groups. These 
beneficial effects on postoperative immunosuppression could be related to an enhancement 
in pulmonary function since maintaining MV during CPB abolished the postoperative 
decrease of PaO2 /FiO2 ratio.  
Firstly, cardiac surgery with CPB induced postoperative immunosuppression. This effect has 
been well characterized and previous studies have demonstrated that HLA-DR expression 
was significantly decreased, and IL-10 was increased after cardiac surgery [4,5,18]. The loss 
of HLA-DR expression on monocyte, which indicates their functional deactivation, had 
previously been described after cardiac surgery and sepsis [5], and the persistence of this 
alteration is associated with severity, nosocomial infection, and death [7,22]. IL-10 is an 
immunosuppressive cytokine which could be involved in HLA-DR down regulation [23] and 
an increase in TNF-α has been shown to be counterbalanced by early expression of anti-
inflammatory IL-10 [24].  Thus, strategies that could decrease postoperative IL-10 levels 
could be of interest to decrease postoperative infectious complications. In agreement, we 
found that total lymphocyte count was significantly decreased after cardiac surgery in non-
ventilated patients compared to patients ventilated during CPB.  Lymphopenia has been 
associated with immune dysfunction during septic shock and it has been shown that low 
absolute lymphocyte counts were predictive of postoperative sepsis [25-26]. In a recent 
retrospective study, Drewry et al. have demonstrated that persistent lymphopenia after 
sepsis predicted mortality, and could be a valuable biomarker of immunosuppression since 
lymphopenia predicted an increased risk of secondary infection [27]. Lastly, we found an 
increased number of CD14+HLA-DRlo/- monocytes after cardiac surgery. This phenotype is 
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consistent with a monocytic-MDSC phenotype. To our knowledge, no study has previously 
reported this finding. MDSC comprise a heterogeneous population of immature myeloid cells 
at different stages of differentiation [19,20]. Although many subtypes of MDSC have been 
described in mice and humans, they can be classified into two major subsets: a monocytic 
MDSC population (CD14+HLA-DRlo/-) and a granulocytic MDSC population ([CD3, CD19, 
CD56, CD14]-CD15+HLA-DR-). Those cells have been shown to be increased in critically ill 
patients and associated with a poor prognosis [28]. This finding raises the question of 
targeting those cells to reduce immunosuppression after cardiac surgery. However, as the 
proportion of CD14+-HLA-DRlo/- monocytes was not different between both groups, 
mechanical ventilation doesn't seem to have any impact on HLA-DR expression.   
Since we found significantly lower TNF-α and IL-10 plasma levels, as well as an increased 
lymphocyte count in ventilated patients compared to non-ventilated patients during CPB, we 
assume that maintaining MV during CPB may decrease both pro- and compensatory anti-
inflammatory responses by preventing lung injury and/or atelectasis.  
Indeed, we found that maintaining MV during CPB improved postoperative index of 
oxygenation. This result was expected and several studies have already demonstrated the 
beneficial effects of MV with PEEP during cardiac surgery with CPB [10-12]. As previously 
reported, postoperative plasmatic levels of CXCL10 and CCL2 were significantly increased 
[29]. CXCL10 is involved in acute lung injury and ARDS and induces neutrophils migration 
into the lung [30]. In particular, a recent study has shown that CXCL10 and its receptor 
CXCR3 were critical factors for the exacerbation of the pathology of ARDS [31].  CCL2 has 
been shown to be involved in neutrophils recruitment during ARDS.  In a mouse model of 
ARDS, neutralization of this chemokine significantly decreased severity of lung injury [32]. 
Our ventilation strategy did not have a significant influence on post-CPB increased 
permeability edema since postoperative levels of CCL2 and CXCL10 were similar in 
ventilated and non-ventilated patients with a similar count of PMN. Thus, we believe that 
maintaining ventilation during CPB decreases rather the occurrence of post-CPB atelectasis 
which has been regarded as a main cause of post-CPB lung injury [13-14]. Furthermore, we 
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found that maintaining MV during CPB significantly decreased postoperative levels of TNF-α. 
TNF-α is released by a large number of pulmonary cells including alveolar macrophages and 
epithelial cells including pulmonary cells (alveolar macrophages and pulmonary epithelial 
cells…) and has been considered as a marker of lung injury [15,33,]. Occurrence of 
atelectasis when MV is discontinued during CPB [13,14,34] could generate alveolar injury 
and inflammation in the surrounding lung tissue [16] which could be worsened by MV after 
CPB (ie atelectrauma). Alternatively, hypoxia associated with atelectasis may be injurious 
and has been associated with an increased wet-to-dry ratio in an animal study [15,17,].  
 
 
Limitations 
This study has several limitations. First, it is an observational study and the lack of 
randomization may have induced some bias. We found a difference between two groups with 
a significantly higher BMI in the ventilated group, and a nearly statistically significant 
difference in baseline PaO2 /FiO2 ratio.  Despite BMI having been described as a risk factor 
for early onset of severe pulmonary dysfunction after surgery [35], we still found that PaO2 
/FiO2 ratio was improved in ventilated patients. Secondly, in contrast to murine MDSC, 
human MDSC are not so clearly defined because of the lack of specific markers. Although 
CD14+HLA-DRlow/neg phenotype is consistent with a Mo-MDSC phenotype, in vitro studies 
would be required to confirm the suppressive properties of those cells after CPB [20]. 
 
 
 
 
Acknowledgment: we thank Eric Barr for his careful review of the manuscript 
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Figure legends 
 
 
Figure 1: Design of the study and gating strategy for HLA-DR monocytic expression 
measurement.  
(A) Design of the study. 
(B) Following an initial FS/SS discrimination of the monocytic subset, CD14+ monocytes were 
gated, and HLA-DR mean fluorescence intensity (MFI) was measured before (T1) and after 
CBP (T2). Green areas represent mean channel fluorescence for FITC anti-HLA-DR. Unfilled 
histograms are isotype control results from the same sample. As monocytic MDSC (Mo-
MDSC) in humans were previously described as CD14+HLA-DRlo/- monocytes, we also 
quantified the proportion of this subset among CD14+ monocytes.  
CBP, Cardio-pulmonary bypass; CCL2, Chemokine ligand-2; CXCL-10, CXC motif 
chemokine-10; IL-10, Interleukin-10; FS, Forward scatter; ICU, Intensive care unit; mHLA-DR, 
Monocytic expression of human leukocyte antigen-DR; MV, Mechanical ventilation; 
PaO2/Fi02, Ratio of arterial oxygen tension over inspired oxygen fraction; PEEP, Positive 
end-expiratory pressure; RR, respiratory rate; SS, Side scatter; TNF-α, Tumor necrosis factor 
alpha. 
 
Figure 2: Effects of maintaining mechanical ventilation during CPB on pulmonary 
function 
(A) Variation of PaO2/FiO2 ratio between pre- (T1) and post-CBP time (T2) in patients with 
(MV+) and without (MV-) mechanical ventilation during CPB. 
(B) Plasma levels of CCL2 and CXCL10 before (T1) and after (T2) CPB.  
(C) Plasma levels of CCL2 and CXCL10 according to maintenance (MV+) or not (MV-) of 
mechanical ventilation during CBP.  
Boxes represent median, 25th and 75th percentiles. Whiskers represent 5th and 95th 
percentiles. Bars on dot plots represent medians. P values were obtained using Mann-
Whitney U test for comparisons between MV+ and MV- groups, and Wilcoxon match-pairs 
signed rank test for comparisons between T1 and T2 periods within each group.  
CCL2, Chemokine ligand 2; CXCL-10, CXC motif chemokine 10; MV, Mechanical ventilation; 
PaO2/Fi02, Ratio of arterial oxygen tension over inspired oxygen fraction; T1, before 
cardiopulmonary bypass; T2, After cardiopulmonary bypass. 
 
Figure 3: Immunological effect of CPB during cardiac surgery 
(A) HLA-DR expression on CD14+ monocytes determined by flow cytometry, and proportion 
of CD14+HLA-DRlo monocytes among CD14+ monocytes, before (T1) and after (T2) CPB.  
(B) Plasma levels of TNF-α and IL-10 before (T1) and after (T2) CBP. 
(C) Number of circulating neutrophils (PMN), lymphocytes and monocytes before (T1) and 
after (T2) CBP. 
(D) Correlation between circulating lymphocyte count and plasma level of IL-10 after CPB 
(T2).  
P values were obtained using Wilcoxon match-pairs signed rank test for comparisons 
between T1 and T2 periods. Correlations were investigated using the nonparametric 
Spearman rank correlation test.  
IL-10, Interleukin-10; mHLA-DR, Monocytic expression of human leukocyte antigen-DR; MFI, 
Mean fluorescence intensity; MV, Mechanical ventilation; PaO2/Fi02, Ratio of arterial oxygen 
tension over inspired oxygen fraction; T1, before cardiopulmonary bypass; T2, After 
cardiopulmonary bypass; TNF-α, Tumor necrosis factor alpha. 
 
 
 
Figure 4: Immunological effect of maintaining mechanical ventilation (MV) during CPB 
(A) Plasma levels of TNF-α and IL-10, (B) Number of circulating neutrophils (PMN), 
lymphocytes and monocytes, (C) Number of circulating lymphocytes at day 2, (D) expression 
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of HLA-DR on CD14+ monocytes and (E) percentage of CD14+HLA-DRlo/- monocytes 
according to maintenance (MV+) or not (MV-) of mechanical ventilation during CPB.  
Bars on dot plots represent medians. P values were obtained using Mann-Whitney U test for 
comparisons between MV+ and MV- groups, and Wilcoxon match-pairs signed rank test for 
comparisons between T1 and T2 periods within each group. 
IL-10, Interleukin-10; mHLA-DR, Monocytic expression of human leukocyte antigen-DR; MFI, 
Mean fluorescence intensity; MV, Mechanical ventilation; PMN, Neutrophils; T1, before 
cardiopulmonary bypass; T2, after cardiopulmonary bypass; TNF-α, Tumor necrosis factor 
alpha. 
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 MV- 
N=25 
MV+ 
N=25 
p 
Age (years) 75[65-79] 73[69-80] 0.79 
Surgery 
- Valvular replacement 
- CABG 
- Mixed (valvular and CABG) 
 
17 
5 
3 
 
8 
9 
8 
 
BMI (kg/m2) 26[23-28] 30[27-33] 0.007 
Euroscore II 2.2[1.4-2.9] 2.3[1.4-3.3] 0.6 
CVP before CPB (mmHg) 7[6-10] 10[7-12] 0.15 
mPAP before CPB (mmHg) 23[20-24] 19[11-25] 0.28 
P/F ratio before CPB 326[225-381] 240[173-320] 0.07 
 
Table1. Baseline characteristics of patients before CBP 
 
 
 
 MV- 
N=25 
MV+ 
N=25 
p 
CVP after CPB (mmHg) 8[6-11] 11[8-12] 0.16 
mPAP after CPB (mmHg) 19[18-27] 21[16-24] 0.74 
P/F ratio after CPB 276[199-360] 242[211-310] 0.34 
CPBP duration (min) 61[52-76] 54[48-68] 0.32 
Surgery duration (min) 170[148-210] 150[139-182] 0.3 
ICU stay (days) 3[3-6] 3[3-5] 0.59 
Hospital stay (days) 10[4-16] 10[4-13] 0.52 
Postoperative Infections 5 (20%) 2 (8%) 0.5 
 
Table 2. Effects of mechanical ventilation on outcome and clinical parameters.  
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